Mood Profile Test Panel

Description

Our Mood Profile Panel identifies nutrient deficiencies that may contribute each patient’s susceptibility to mood disorders. About 350 million people worldwide suffer from behavioral health issues such as depression or anxiety. Although the physiological basis behind these crippling mood disorders is not completely understood, several biochemical factors (such as serotonin and dopamine) are scientifically proven to affect mental health and perceptions of panic or anxiety. Several genetic markers have been identified that affect metabolic pathways in the body involving dopamine, serotonin, epinephrine, and folate; all known to be associated with depression and anxiety.

The UMBRELLA Mood Profile Panel analyzes multiple genes to determine whether there are any identifiable mutations known to affect these pathways, providing information that can help patients manage the mood disorder specific to their genetic code.

Mood Profile Panel Genetic Markers Include

Ideal Candidates Have The Following Symptoms Or Conditions

• Mood Disorders
• Compromised Diet
• High Stress Lifestyle
• Significant toxin exposure (environmental or diet)

Scientific References

1. Lachman H et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-250.
2. Weinshilboum R et al. Methylation Pharmacogenetics: Catechol-O methyltransferase, Thiopurine Methyltransferase, and Histamine N-Methyltransferase. Annu. Rev. Pharmacol. Toxicol. 1999; 39:19-52.
3. Genetics Home Reference. Genes: COMT. http://ghr.nlm.nih.gov/gene/COMT.
4. Mier D et al. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Molecular Psychiatry. 2010; 15:918-927.
5. Lester K et al. Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biology of Mood & Anxiety Disorders. 2013; 3:4.
6. Cheng JB et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A. 2004; 101:7711–7715.
7. Ahn J et al. Genome-wide association study of circulating vitamin D levels. Human Molecular Genetics. 2010; 19(13): 2739-2745.
8. Nissen J et al. Vitamin D Concentrations in Healthy Danish Children and Adults. PLOS One. 2014; 9(2):e89907.
9. Harris HW et al. Supplementation might help patients with depression, seasonal mood disturbances. Current Psych. 2013; 12(4):19-25.
10. Houssein-Nezhad A et al. Vitamin D for Health: A Global Perspective. Mayo Clin. Proc. 2013; 88(7):720-755.
11. Kelly RJ et al. Sequence and expression of a candidate for the human Secretor blood group alpha (1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem. 1995; 270:4640–4649.
12. Hazra A et al. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Gen. 2009; 18(23):4677-4687.
13. Semmes BJ. Depression: a role for omega-3 fish oils and B vitamins? Evid. Based Integr. Med. 2005; 2:229–237.
14. Tiemeier H et al. Vitamin B12, Folate, and Homocysteine in Depression: The Rotterdam Study. Am J Psychiatry. 2002; 159:2099-2101.
15. Frankenburg, FR. The role of one-carbon metabolism in schizophrenia and depression. Harv. Rev. Psychiatry. 2007; 15:146–160.
16. Seppälä et al. Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study. BMC Psychiatry 2013;13:145.
17. Tanaka T et al. Genome-wide Association Study of Vitamin B6, Vitamin B12, Folate, and Homocysteine Blood Concentrations. The American Journal of Human Genetics. 2009; 84:477-482.
18. Gozdzik A et al. Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH)D concentrations in a sample of young Canadian adults of different ancestry. J Steroid Biochem Mol Biol. 2011; 127:405–412.
19. Ahn J et al. Genome-wide association study of circulating vitamin D levels. Human Molecular Genetics. 2010; 19(13) 2739-2745.
20. Nissen J et al. Vitamin D Concentrations in Healthy Danish Children and Adults. PLOS One. 2014; 9(2):e89907.
21. Foucan L et al. Polymorphisms in GC and NADSYN1 Genes are associated with vitamin D status and metabolic profile in non-diabetic adults. BMC Endocrine Disorders. 2013; 13:36.
22. Wang T et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010; 376(9736):180-188.
23. Grober U et al. Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare. Dermato-Endocrinology. 2013; 5(3):331-47.
24. Bischoff-Ferrari HA et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012; 367:40–9.
25. Bjelland I et al. Folate, Vitamin B12, Homocysteine, and the MTHFR 677CT Polymorphism in Anxiety and Depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry. 2003; 60(6):618-626.
26. Beydoun MA et al. Serum folate, vitamin B-12 and homocysteine and their association with depressive symptoms among US adults. Psychosom Med. 2010;72(9):862-873.
27. Refsum H et al. The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease. J Nutr. 2006; 136:1731S-1740S.
28. Frosst P et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10:111–113.
29. Lewis SJ et al. The thermolabile variant of MTHFR is associated with depression in the British Women’s Heart and Health Study and a meta-analysis. Molecular Psychiatry. 2006; 11:352-360.
30. Van der Put NM et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998; 62(5):1044–51.
31. Weisberg I et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998; 64:169–72.
32. Nurk E et al. Plasma Total Homocysteine and Memory in the Elderly: The Hordaland Homocysteine Study. Ann Neurol. 2005; 58:847-857.
33. Rajagopalan P et al. Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. Neuroimage Clin. 2012; 1(1):179-187. 179-187.
34. Lewis SJ et al. The thermolabile variant of MTHFR is associated with depression in the British Women’s Heart and Health Study and a meta-analysis. Molecular Psychiatry. 2006; 11:352-360.
35. Gilbody S et al. Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review. Am J Epidemiol. 2007;165:1-13.